If anyone is looking for a small cap medical device company that is growing faster than the weeds in my backyard I suggest taking a look at . They just reported a blowout quarter and raised guidance for the full year.
I was in recently but they announced a secondary stock offering at $22 which caused a massive pullback in the stock price. I got nervous and sold my shares at $21.84 on 7/16 for a small loss but considering the numbers they just posted I’m now back in at $20.35
makes medical devices to treat chronic and acute pain.
The market cap is only $640M so this stock is not even on the radar yet for most fund managers but it will be soon.
The market cap is only $640M so this stock is not even on the radar yet for most fund managers but it will be soon.
2020 Q2:
Revs up 87% YoY to $19.3M
Gross margin: 79%
EPS up 50% to $.09
Cash: $17M
Q3 Guidance: Revs up 91% YoY
should do $85-90M this year so only selling at 7.5x 2020 sales with 90% rev growth, 79% gross margins and they’re profitable. Win. Win. Win. Win.
Revs up 87% YoY to $19.3M
Gross margin: 79%
EPS up 50% to $.09
Cash: $17M
Q3 Guidance: Revs up 91% YoY
should do $85-90M this year so only selling at 7.5x 2020 sales with 90% rev growth, 79% gross margins and they’re profitable. Win. Win. Win. Win.
I think gets back to the recent highs of $28 in the next 2 weeks then blows through $30 and gets to $40 by year end making a double bagger in the next 5 months.
should do at least $160M revs and $.60 EPS in 2021 — this stock clearly deserves a premium multiple given their growth rate and the fact they’re already profitable so 30x revs would put the stock price at $141/share providing some nice upside potential from here.
To be honest 30x revenues is cheap for a company going at 90% with 80% gross margins and positive EPS. This stock honestly feels like an early Christmas present under $21 per share. There’s no way stays this cheap for much longer.
is trading down to $19.20 right now so grab some while you can. I just doubled my position so my cost basis is now $19.80 — I’m planning to hold this stock for the next year.
No clue why is trading below $19. Sometimes the market is wrong. Maybe I’m wrong. Just hard to ignore 90% revenue growth with 80% margins and positive EPS. I’m just keep adding more.
